Neurogenic Bowel Clinical Trials

Find Neurogenic Bowel Clinical Trials Near You

High Fermented Food Intake to Improve Gut Microbiome and Bowel Dysfunction in Individuals With SCI

Status: Recruiting
Location: See location...
Intervention Type: Other, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn whether consuming a high fermented food diet improves bowel function and gut health in adults with chronic spinal cord injury (SCI). The study will also evaluate the feasibility and tolerability of consuming fermented foods daily for 10 weeks. The main questions it aims to answer are: 1. Does a high fermented food diet improve neurogenic bowel dysfunction symptoms and colonic transit in adults with SCI? 2. Does fermented food intake change gut microbiome composition, short-chain fatty acid production, and intestinal inflammation? Researchers will compare a high fermented food diet to a control diet to evaluate effects on bowel health and gut microbiome outcomes. Participants will: * Consume study foods daily for 10 weeks * Attend 2 in-person study visits * Collect stool samples at home and ship them overnight to the research team using provided collection kits and prepaid shipping materials * Complete bowel health questionnaires and dietary recalls * Undergo Sitz marker testing with abdominal X-rays to assess colonic transit * Participate in biweekly monitoring contacts throughout the study period

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Adults aged 18-70 years

• At least 1 year post-onset of spinal cord injury, consistent with chronic spinal cord injury

• Traumatic spinal cord injury involving cervical or thoracic levels

• American Spinal Injury Association Impairment Scale classification A-D

• Medically stable, with no recent hospitalizations or acute illnesses

• Able to safely consume study foods, including fermented and control food products

• Experiencing neurogenic bowel dysfunction, defined by at least one of the following:

‣ Three or fewer bowel movements per week

⁃ More than 60 minutes required per bowel care routine

⁃ Symptoms of incomplete evacuation

⁃ Abdominal distension

⁃ Fecal incontinence

• Established and stable bowel program, defined as a consistent individualized routine of timing, frequency, and evacuation methods that has remained unchanged for at least 4 weeks before enrollment

Locations
United States
Ohio
Ohio State University
RECRUITING
Columbus
Contact Information
Primary
Jia Li, PhD
jia.li@osumc.edu
6146889094
Time Frame
Start Date: 2026-10-01
Estimated Completion Date: 2029-07-31
Participants
Target number of participants: 44
Treatments
Experimental: Fermented Food Arm
Fermented food arm: participants randomized to the fermented foods arm will consume ≥6 servings/day of fermented foods after a graded ramp-up to minimize intolerance. A 3-week ramp-up (weeks 1-3) will increase intake from 2 to 6 servings/day, followed by a 7-week full-intake phase (weeks 4-10). To avoid single-food dominance and improve microbiome diversity, participants will be required to consume ≥3 categories/day (e.g., vegetables, dairy, soy, tea, brine) and rotate through all core fermented food categories and consume a variety of items across a 2-3-day period. This will ensure all core items are consumed throughout the week. Core food items will be delivered biweekly.
Placebo_comparator: Control Diet Arm
Participants randomized to the control arm will receive non-fermented versions of the base foods consumed by the fermented foods arm and will be instructed to avoid fermented foods during the trial.
Related Therapeutic Areas
Sponsors
Leads: Ohio State University

This content was sourced from clinicaltrials.gov